First Tracks Biotherapeutics, Inc. (TRAX)

NASDAQ: TRAX · Real-Time Price · USD

47.90

+2.47 (5.44%)

At close: Nov 6, 2026, 4:00 PM EST

47.00

-0.90 (-1.88%)

After-hours: Nov 6, 2026, 7:56 PM EST

TRAX Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Selling, General & Admin	48.36	39.39	28.76	20.87
Research & Development	109	139.61	152.35	90.26
Operating Expenses	157.36	179.01	181.1	111.12
Operating Income	-157.36	-179.01	-181.1	-111.12
Interest & Investment Income	7.57	12.94	17.38	12.31
Other Non Operating Income (Expenses)	-0.01	-0.02	0.01	-0
EBT Excluding Unusual Items	-149.8	-166.09	-163.71	-98.81
Pretax Income	-149.8	-166.09	-163.71	-106.15
Net Income	-149.8	-166.09	-163.71	-106.15
Net Income to Common	-149.8	-166.09	-163.71	-106.15
Net Income Growth	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Free Cash Flow	-110.17	-143.01	-126.16	-93.81
EBITDA	-156.91	-178.45	-180.5	-110.47
D&A For EBITDA	0.45	0.56	0.61	0.65
EBIT	-157.36	-179.01	-181.1	-111.12